Titre:
  • Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.
Auteur:Marechal, Raphaël; Bachet, Jean-Baptiste; Mackey, John R; Dalban, Cécile; Demetter, Pieter; Graham, Kathryn; Couvelard, Anne; Svrcek, Magali; Bardier-Dupas, Armelle; Hammel, Pascal; Sauvanet, Alain; Louvet, Christophe; Paye, François; Rougier, Philippe; Penna, Christophe; André, Thierry; Dumontet, Charles; Cass, Carol E; Jordheim, Lars Petter; Louvet, Christophe; Closset, Jean; Salmon, Isabelle; Devière, Jacques; Emile, Jean-François; Van Laethem, Jean-Luc
Informations sur la publication:Gastroenterology, 143, 3, page (664-674), e1-6
Statut de publication:Publié, 2012-09
Sujet CREF:Sciences humaines
Mots-clés:Biomarker
Drug Metabolism
Nucleoside Transporters
Pancreatic Cancer
MeSH keywords:Antimetabolites, Antineoplastic -- metabolism -- therapeutic use
Biological Transport
Biotransformation
Carcinoma, Pancreatic Ductal -- chemistry -- drug therapy -- mortality -- pathology -- surgery
Chemotherapy, Adjuvant
Chi-Square Distribution
Deoxycytidine -- analogs & derivatives -- metabolism -- therapeutic use
Deoxycytidine Kinase -- analysis
Equilibrative Nucleoside Transporter 1 -- analysis
Female
France
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Multivariate Analysis
Pancreatectomy
Pancreatic Neoplasms -- chemistry -- drug therapy -- mortality -- pathology -- surgery
Proportional Hazards Models
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Tissue Array Analysis -- methods
Treatment Outcome
Tumor Suppressor Proteins -- analysis
Note générale:Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0016-5085
info:doi/10.1053/j.gastro.2012.06.006
info:pii/S0016-5085(12)00822-0
info:scp/84865474189
info:pmid/22705007